![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
C-SALVAGE: GRAZOPREVIR (GZR; MK-5172), ELBASVIR (EBR; MK-8742) AND RIBAVIRIN (RBV) FOR CHRONIC HCV-GENOTYPE 1 (GT1) INFECTION AFTER FAILURE OF DIRECT-ACTING ANTIVIRAL (DAA) THERAPY
|
|
|
Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
Download the PDF here
![EASL1.gif](../images/042315/042315-1/EASL1.gif)
![EASL2.gif](../images/042315/042315-1/EASL2.gif)
![EASL3.gif](../images/042315/042315-1/EASL3.gif)
![EASL4.gif](../images/042315/042315-1/EASL4.gif)
![EASL5.gif](../images/042315/042315-1/EASL5.gif)
![EASL6.gif](../images/042315/042315-1/EASL6.gif)
![EASL7.gif](../images/042315/042315-1/EASL7.gif)
![EASL8.gif](../images/042315/042315-1/EASL8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|